Novo Nordisk A/S
A Hospital Key Account Manager at Novo Nordisk Rare Disease drives scientific dialogue with Healthcare Professionals and manages key accounts across Spain's rare blood disorders territories. The role involves developing long-term business relationships, interpreting clinical data to create practice-relevant messages, and securing product availability through negotiation. Success requires translating business plans into actionable strategies while providing medical support to diverse stakeholders to maximize sales and patient impact.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
61% below the average for this role
Key Account Manager - Rare Blood Disorders
State of Indiana
Medical Advisor, Rare Disease - UK
State of Indiana
Key Account Associate/ Senior Key Account Associate/ Key Account Executive (Macau)
AstraZeneca
Medical Advisor - Rare Disease
State of Indiana
Key Account Manager Rare Disease
Ipsen
Medical Advisor %E2%80%93 Rare Diseases Hematology Riyadh Saudi Arabia
AstraZeneca